Congresswoman Lori Trahan will see first-hand Rapid Micro Biosystems specialized technology and meet with employees to gain more insight.
LOWELL, MA – Rapid Micro Biosystems in Lowell, MA is pleased to welcome Congresswoman Lori Trahan (D-3rd) to its global headquarters on Pawtucket Blvd in Lowell tomorrow, November 6th. Congresswoman Trahan will tour the manufacturing facility and meet with approximately 100 employees on site.
Rapid Micro Biosystems’ (RMB) Growth Direct™, the first and only growth-based system to fully automate traditional microbial testing and detect contamination more quickly, delivering compelling economic benefits to manufacturers while improving their quality control operations, securing data integrity processes, and reducing operational risks. RMB’s rapid detection and validation of contaminants allows for faster production and the release of critical medicines to patients, such as vaccines and cell and gene therapies.
Congresswoman Trahan is visiting to witness first-hand this exciting technology designed and manufactured in her district and to hear from employees not only about their work at the company, but about other issues affecting them, their families and the community. “Rapid Micro Biosystems is a growing company right here in our community that is leading the charge on the next generation of medical innovation. Their technology to accurately and efficiently detect microbial contamination in the manufacture of pharmaceuticals, biologics, biotechnology products, medical devices, and other personal care products helps safeguard the American people’s peace of mind any time they are taking a medication or undergoing a medical procedure. I am proud of the work this company is undertaking and look forward to the opportunity to meet their employees and learn more about the organization,” said Congresswoman Trahan.
RMB, a fast-growing company, is increasing jobs by over 20% per year. This life sciences technology company is an important contributor to the Lowell economy and more broadly to the safety and quality of pharmaceutical manufacturing. “It’s our honor to host Congresswoman Trahan so she can meet and interact with our great team and learn more about how RMB is partnering with pharmaceutical companies around the world to improve the safety and availability of medications” said Robert Spignesi, Chief Executive Officer of RMB.
About Congresswoman Lori Trahan (D-3rd)
Lori Trahan was born and raised in a working-class family in Lowell, Massachusetts. Her father was a union ironworker and her mother was a domestic worker who juggled various part time jobs while raising four girls. The first in her family to graduate from college, Lori earned a scholarship to play Division 1 volleyball at Georgetown University. She joined the staff of former Congressman Marty Meehan as a scheduler, eventually working her way up to Chief of Staff. Following her public service, Lori began working in the private sector as the only female executive at a tech company before moving on to cofound a woman owned and operated consulting firm, Concire, where she advised various companies on business strategy, how to create the conditions for employees – especially women - to thrive. She and her husband, Dave, currently reside in Westford, MA and are raising two young girls, Grace and Caroline, while keeping tabs on their three grown stepsons, Thomas, Dean, and Christian.
As a member of the House Education and Labor and House Armed Services Committees, Lori is focused on fighting for working families on issues such as affordable health care, quality public education, workforce development, the environment, and working to end the pain and suffering of the opioid crisis. Lori is the first Portuguese-American woman elected to Congress and is a member of the New Dems and the Congressional Progressive Caucus.
About Rapid Micro Biosystems
Rapid Micro Biosystems (RMB) creates, sells, validates and services innovative products for fast, accurate, and efficient detection of microbial contamination in the manufacture of pharmaceuticals, biologics, biotechnology products, medical devices, and personal care products. The company’s Growth Direct™—the first and only growth-based system to automate rapid compendial QC Micro testing—ensures data integrity, compliance, and operational efficiencies driven by rapid methods and automation. RMB is dedicated to providing groundbreaking technology and products to support companies in their journey to achieve greater reliability, efficiency, and better predictability, ultimately providing higher quality products for improved patient outcomes. For more information, visit www.rapidmicrobio.com. Follow RMB at @rapidmicrobio or LinkedIn.